As the IL-6/STAT3 pathway is an important pathway that regulates the progression of colon cancer, inhibition of this pathway by Luteolin provided new insight into the therapeutic potential and mechanisms of Luteolin for colon cancer treatment [54]. Here, STAT3 is linked to malignant colon neoplasm.